Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SarCNU in recurrent/metastatic colorectal cancer
NCT00028015Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Oct 2001
- Primary completion
- Sep 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of sarmustine in colorectal cancer (CRC), sponsored by Canadian Cancer Trials Group. Started Oct 2001; status: completed.
02
Drugs
sarmustine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00028015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028015.